Go Pro
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$10.90 0.00 (0.00%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$10.90 -0.01 (-0.05%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Advanced

Key Stats

Today's Range
$10.87
$11.29
50-Day Range
$7.34
$11.58
52-Week Range
$3.74
$11.76
Volume
1.84 million shs
Average Volume
3.32 million shs
Market Capitalization
$4.23 billion
P/E Ratio
181.67
Dividend Yield
N/A
Price Target
$11.50
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

LFST MarketRank™: 

LifeStance Health Group scored higher than 73% of companies evaluated by MarketBeat, and ranked 194th out of 834 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LifeStance Health Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow by 75.00% in the coming year, from $0.12 to $0.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is 181.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is 181.67, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.14.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about LifeStance Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.53% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 2.67, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 1.72%, indicating that investor sentiment is improving.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • News Sentiment

    LifeStance Health Group has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.
  • Search Interest

    15 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 275% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $63,579,701.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFST Stock News Headlines

Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.04 at the start of the year. Since then, LFST shares have increased by 54.8% and is now trading at $10.90.

LifeStance Health Group, Inc. (NASDAQ:LFST) released its earnings results on Wednesday, May, 6th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The business's revenue for the quarter was up 21.2% on a year-over-year basis.
Read the conference call transcript
.

LifeStance Health Group's Board of Directors authorized a stock repurchase plan on Wednesday, February 25th 2026, which authorizes the company to buy back $100,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's leadership believes its shares are undervalued.

LifeStance Health Group (LFST) raised $640 million in an initial public offering on Wednesday, June 9th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

LifeStance Health Group's top institutional shareholders include Everhart Financial Group Inc. (0.03%), Contravisory Investment Management Inc. (0.01%) and Handelsbanken Fonder AB (0.01%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Paula Cipollone and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/06/2026
Today
7/26/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,961
Year Founded
2017

Price Target and Rating

High Price Target
$15.00
Low Price Target
$8.00
Potential Upside/Downside
+5.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.06
Trailing P/E Ratio
181.67
Forward P/E Ratio
90.83
P/E Growth
N/A
Net Income
$9.66 million
Net Margins
1.55%
Pretax Margin
2.25%
Return on Equity
1.56%
Return on Assets
1.07%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.48
Quick Ratio
1.48

Sales & Book Value

Annual Sales
$1.42 billion
Price / Sales
2.97
Cash Flow
$0.17 per share
Price / Cash Flow
64.80
Book Value
$3.91 per share
Price / Book
2.79

Miscellaneous

Outstanding Shares
387,830,000
Free Float
374,260,000
Market Cap
$4.23 billion
Optionable
Optionable
Beta
1.12

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 7/27/2026 by MarketBeat.com Staff.
From Our Partners